EHI
ALKS icon

Eagle Health Investments’s Alkermes ALKS Stock Holding History

Eagle Health Investments’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.44M Buy
238,673
+156,873
+192% +$4.87M 1.48% 23
2025
Q4 		$2.29M Hold
81,800
– – 0.5% 27
2025
Q3 		$2.45M Buy
+81,800
New +$2.31M 0.64% 20

Other funds holding ALKS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Eagle Health Investments's ALKS Position: Q1 2026 in Review

Eagle Health Investments increased its Alkermes (ALKS) stake by 192% in Q1 2026, buying an estimated $4.87M and bringing the position to 238,673 shares worth $8.44M. The position accounts for 1.48% of the portfolio, ranked #23.

Eagle Health Investments first reported a position in ALKS in Q3 2025 and has held it in 3 quarters since. 389 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • Eagle Health Investments held 238,673 shares of Alkermes worth $8.44M as of Q1 2026.
  • Eagle Health Investments bought 156,873 Alkermes shares in Q1 2026, an estimated $4.87M.
  • Alkermes made up 1.48% of Eagle Health Investments's portfolio in Q1 2026, its #23 holding.
  • Eagle Health Investments first reported a position in Alkermes in Q3 2025 and has held it in 3 quarters since.
  • 389 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on Eagle Health Investments's 13F filing for Q1 2026, filed 15 May 2026.